Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Flanagan

Showing results (481-490 of 508) with videos related to

Pageof 51
Sort By:
Journal of Medicinal Chemistry|January 4, 2018
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune DiseasesMichael L Vazquez, Neelu Kaila, Joseph W Strohbach, et al.
The Journal of Clinical Investigation|November 9, 2020
YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stressElisa De Franco, Maria Lytrivi, Hazem Ibrahim, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2012
Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infectionsMark J Mitton-Fry, Joel T Arcari, Matthew F Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesisIntza Garin, Emma L Edghill, Ildem Akerman, et al.
Cell Reports. Medicine|December 23, 2025
Pharmacologic reversal of advanced Alzheimer's disease in mice and identification of potential therapeutic nodes in human brainKalyani Chaubey, Edwin Vázquez-Rosa, Sunil Jamuna Tripathi, et al.
Journal of Medicinal Chemistry|June 6, 2013
Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infectionsThomas V Magee, Matthew F Brown, Jeremy T Starr, et al.
Research Square|August 13, 2025
Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratificationSathyaseelan Chakkarai, Michal Sadowski, Qiong Yang, et al.
Brain : a Journal of Neurology|May 1, 2019
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group reportPeter T Nelson, Dennis W Dickson, John Q Trojanowski, et al.
Journal of the American Society of Nephrology : JASN|April 5, 2017
Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphomannomutase 2Oscar Rubio Cabezas, Sarah E Flanagan, Horia Stanescu, et al.
Journal of Medicinal Chemistry|September 25, 2009
Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infectionsThomas V Magee, Sharon L Ripp, Bryan Li, et al.
Pageof 51

Showing results (481-490 of 508) with videos related to

Sort By:
Pageof 51
Journal of Medicinal Chemistry|January 4, 2018
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune DiseasesMichael L Vazquez, Neelu Kaila, Joseph W Strohbach, et al.
The Journal of Clinical Investigation|November 9, 2020
YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stressElisa De Franco, Maria Lytrivi, Hazem Ibrahim, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2012
Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infectionsMark J Mitton-Fry, Joel T Arcari, Matthew F Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesisIntza Garin, Emma L Edghill, Ildem Akerman, et al.
Cell Reports. Medicine|December 23, 2025
Pharmacologic reversal of advanced Alzheimer's disease in mice and identification of potential therapeutic nodes in human brainKalyani Chaubey, Edwin Vázquez-Rosa, Sunil Jamuna Tripathi, et al.
Journal of Medicinal Chemistry|June 6, 2013
Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infectionsThomas V Magee, Matthew F Brown, Jeremy T Starr, et al.
Research Square|August 13, 2025
Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratificationSathyaseelan Chakkarai, Michal Sadowski, Qiong Yang, et al.
Brain : a Journal of Neurology|May 1, 2019
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group reportPeter T Nelson, Dennis W Dickson, John Q Trojanowski, et al.
Journal of the American Society of Nephrology : JASN|April 5, 2017
Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphomannomutase 2Oscar Rubio Cabezas, Sarah E Flanagan, Horia Stanescu, et al.
Journal of Medicinal Chemistry|September 25, 2009
Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infectionsThomas V Magee, Sharon L Ripp, Bryan Li, et al.
Pageof 51